Year: 2017
Type: review
Abstract: TBVAC2020 is a research project supported by the Horizon 2020 program of the European Commission (EC). It aims at the discovery and development of novel tuberculosis (TB) vaccines from preclinical research projects to early clinical assessment. The project builds on previous collaborations from 1998 onwards funded through the EC framework programs FP5, FP6, and FP7. It has succeeded in attracting new partners from outstanding laboratories from all over the world, now totaling 40 institutions. Next to the development of novel vaccines, TB biomarker development is also considered an important asset to facilitate rational vaccine selection and development. In addition, TBVAC2020 offers portfolio management that provides selection criteria for entry, gating, and priority settings of novel vaccines at an early developmental stage. The TBVAC2020 consortium coordinated by TBVI facilitates collaboration and early data sharing between partners with the common aim of working toward the development of an effective TB vaccine. Close links with funders and other consortia with shared interests further contribute to this goal.
Source: Frontiers in Immunology
Institutions: Max Planck Institute for Infection Biology, London School of Hygiene & Tropical Medicine, TuBerculosis Vaccine Initiative, National Institute for Biological Standards and Control, University of Oxford, Centre National de la Recherche Scientifique, Université Toulouse III - Paul Sabatier, Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, Leiden University Medical Center, Centre Hospitalier Universitaire Vaudois, University Hospital Ulm, Biomedical Primate Research Centre, Public Health England
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $956
Funders: Universität Basel, London School of Hygiene and Tropical Medicine, University of Warwick, Imperial College London, University of Oxford, European Commission, University College Dublin, Universiteit Leiden, Public Health England, Yonsei University, Bangor University, Eidgenössische Technische Hochschule Zürich, Istituto Superiore di Sanità, Universiteit Gent, Universiteit Stellenbosch, Centre National de la Recherche Scientifique, Leids Universitair Medisch Centrum, Université de Genève, Université de Lausanne, Centre Hospitalier Universitaire Vaudois, Animal and Plant Health Agency, Universidad de Zaragoza, University of Cape Town, Universität Ulm, Medical Research Council, Yonsei University College of Medicine, Statens Serum Institut
OpenAlex ID: W2763033987